132 related articles for article (PubMed ID: 8448574)
1. Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody.
Hnatowich DJ; Fritz B; Virzi F; Mardirossian G; Rusckowski M
Nucl Med Biol; 1993 Feb; 20(2):189-95. PubMed ID: 8448574
[TBL] [Abstract][Full Text] [Related]
2. Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin.
Nakamoto Y; Saga T; Sakahara H; Yao Z; Zhang M; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1998 Feb; 25(2):95-9. PubMed ID: 9468022
[TBL] [Abstract][Full Text] [Related]
3. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.
Rusckowski M; Fritz B; Hnatowich DJ
J Nucl Med; 1992 Oct; 33(10):1810-5. PubMed ID: 1403148
[TBL] [Abstract][Full Text] [Related]
4. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
Zhang M; Sakahara H; Yao Z; Saga T; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1997 Jan; 24(1):61-4. PubMed ID: 9080476
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.
Yao Z; Zhang M; Axworthy DB; Wong KJ; Garmestani K; Park L; Park CW; Mallett RW; Theodore LJ; Yau EK; Waldmann TA; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA
Cancer Res; 2002 Oct; 62(20):5755-60. PubMed ID: 12384535
[TBL] [Abstract][Full Text] [Related]
6. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.
Kalofonos HP; Rusckowski M; Siebecker DA; Sivolapenko GB; Snook D; Lavender JP; Epenetos AA; Hnatowich DJ
J Nucl Med; 1990 Nov; 31(11):1791-6. PubMed ID: 2230992
[TBL] [Abstract][Full Text] [Related]
7. Imaging osteomyelitis with streptavidin and indium-111-labeled biotin.
Rusckowski M; Paganelli G; Hnatowich DJ; Magnani P; Virzi F; Fogarasi M; DiLeo C; Sudati F; Fazio F
J Nucl Med; 1996 Oct; 37(10):1655-62. PubMed ID: 8862303
[TBL] [Abstract][Full Text] [Related]
8. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.
Kassis AI; Jones PL; Matalka KZ; Adelstein SJ
J Nucl Med; 1996 Feb; 37(2):343-52. PubMed ID: 8667075
[TBL] [Abstract][Full Text] [Related]
10. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
11. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
[TBL] [Abstract][Full Text] [Related]
12. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
[TBL] [Abstract][Full Text] [Related]
13. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin.
Saga T; Weinstein JN; Jeong JM; Heya T; Lee JT; Le N; Paik CH; Sung C; Neumann RD
Cancer Res; 1994 Apr; 54(8):2160-5. PubMed ID: 8174123
[TBL] [Abstract][Full Text] [Related]
14. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin.
Rosebrough SF
Nucl Med Biol; 1993 Jul; 20(5):663-8. PubMed ID: 8358353
[TBL] [Abstract][Full Text] [Related]
16. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma.
Li GP; Zhang H; Zhu CM; Zhang J; Jiang XF
World J Gastroenterol; 2005 Oct; 11(40):6288-94. PubMed ID: 16419157
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.
Kobayashi H; Sakahara H; Endo K; Hosono M; Yao ZS; Toyama S; Konishi J
Jpn J Cancer Res; 1995 Mar; 86(3):310-4. PubMed ID: 7744702
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
[TBL] [Abstract][Full Text] [Related]
19. New indium-111 labeled biotin derivatives for improved immunotargeting.
Virzi F; Fritz B; Rusckowski M; Gionet M; Misra H; Hnatowich DJ
Int J Rad Appl Instrum B; 1991; 18(7):719-26. PubMed ID: 1787080
[TBL] [Abstract][Full Text] [Related]
20. Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytin.
Alvarez-Diez TM; Polihronis J; Reilly RM
Nucl Med Biol; 1996 May; 23(4):459-66. PubMed ID: 8832700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
